| Cat. No. | Species | Product Description | Structure | Purity | Feature |
|---|---|---|---|---|---|
| ILA-M52H5 | Mouse | Mouse IL-2 R beta Protein, His Tag |  |
|
|
| ILB-H82E3 | Human | Biotinylated Human IL-2 R beta / CD122 Protein, His,Avitag™ |  |
|
|
| ILB-H5253 | Human | Human IL-2 R beta / CD122 Protein, Fc Tag (MALS & SPR verified) |  |
|
|
| CD2-H5221 | Human | Human IL-2 R beta / CD122 Protein, His Tag (SPR verified) |  |
|
|
Human IL-2 R beta, Fc Tag (Cat. No. ILB-H5253) captured on CM5 chip via anti-human IgG Fc antibody can bind IL-2, Tag Free (Cat. No. IL2-H4113) with an affinity constant of 0.473 μM as determined in a SPR assay (Biacore T200) (QC tested).
| Name | Research Code | Research Phase | Company | First Brand Name | First Approved Country | First Indication | First Approved Company | First Approved Date | Indications | Clinical Trials |
|---|---|---|---|---|---|---|---|---|---|---|
| Denileukin diftitox | E-7272; E-7777; DAB-389; LY-335348; DAB389IL-2 | Approved | Eisai Co Ltd | Ontak, Onzar | United States | Lymphoma, T-Cell, Cutaneous | s:9:"Eisai Inc"; | 1999-02-05 | Lymphoma, T-Cell, Peripheral; Leukemia; Lymphoma, B-Cell; Lymphoma, T-Cell, Cutaneous; Lymphoma; Lymphoma, Non-Hodgkin; Leukemia, Lymphocytic, Chronic, B-Cell; Melanoma | Details |
| Basiliximab | CHT-25; chRFT5; CHI-621; SDZ-CHI-621 | Approved | Novartis Pharma Ag | 舒莱, Simulect | Japan | Rejection of organ transplantation | s:18:"Novartis Pharma Ag"; | 1998-05-12 | Rejection of renal transplantation; Rejection of organ transplantation; Colitis, Ulcerative; Uveitis | Details |
| Recombinant humanized anti-CD25 monoclonal antibody (Shanghai CP Guojian) | Approved | Shanghai Cp Guojian Pharmaceutical Co Ltd | 健尼哌 | Mainland China | Rejection of renal transplantation | s:4:"null"; | 2011-01-12 | Rejection of renal transplantation | Details | |
| Daclizumab | R-35; BIIB-019; RO-247375 | Approved | Abbvie Inc, Biogen Inc, F. Hoffmann-La Roche Ltd | Zinbryta, Zenapax | United States | Multiple Sclerosis | s:10:"Biogen Inc"; | 1997-12-10 | Multiple Sclerosis, Relapsing-Remitting; Gastrointestinal Diseases; Inflammatory Bowel Diseases; Multiple Sclerosis; Rejection of organ transplantation; Colitis, Ulcerative; Asthma | Details |
| Recombinant Human Interleukin-2(Ⅰ) (Liaoning Satellite Biological Products) | Approved | Liaoning Satellite Biological Products Research Institute (Limited) | Mainland China | Neoplasms | s:67:"Liaoning Satellite Biological Products Research Institute (Limited)"; | 2002-02-04 | Neoplasms | Details | ||
| Denileukin diftitox | E-7272; E-7777; DAB-389; LY-335348; DAB389IL-2 | Approved | Eisai Co Ltd | Ontak, Onzar | United States | Lymphoma, T-Cell, Cutaneous | s:9:"Eisai Inc"; | 1999-02-05 | Lymphoma, T-Cell, Peripheral; Leukemia; Lymphoma, B-Cell; Lymphoma, T-Cell, Cutaneous; Lymphoma; Lymphoma, Non-Hodgkin; Leukemia, Lymphocytic, Chronic, B-Cell; Melanoma | Details |
| Basiliximab | CHT-25; chRFT5; CHI-621; SDZ-CHI-621 | Approved | Novartis Pharma Ag | 舒莱, Simulect | Japan | Rejection of organ transplantation | s:18:"Novartis Pharma Ag"; | 1998-05-12 | Rejection of renal transplantation; Rejection of organ transplantation; Colitis, Ulcerative; Uveitis | Details |
| Recombinant humanized anti-CD25 monoclonal antibody (Shanghai CP Guojian) | Approved | Shanghai Cp Guojian Pharmaceutical Co Ltd | 健尼哌 | Mainland China | Rejection of renal transplantation | s:4:"null"; | 2011-01-12 | Rejection of renal transplantation | Details | |
| Daclizumab | R-35; BIIB-019; RO-247375 | Approved | Abbvie Inc, Biogen Inc, F. Hoffmann-La Roche Ltd | Zinbryta, Zenapax | United States | Multiple Sclerosis | s:10:"Biogen Inc"; | 1997-12-10 | Multiple Sclerosis, Relapsing-Remitting; Gastrointestinal Diseases; Inflammatory Bowel Diseases; Multiple Sclerosis; Rejection of organ transplantation; Colitis, Ulcerative; Asthma | Details |
| Recombinant Human Interleukin-2(Ⅰ) (Liaoning Satellite Biological Products) | Approved | Liaoning Satellite Biological Products Research Institute (Limited) | Mainland China | Neoplasms | s:67:"Liaoning Satellite Biological Products Research Institute (Limited)"; | 2002-02-04 | Neoplasms | Details |
| Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
|---|---|---|---|---|---|
| Inolimomab | B-B10; BT-563; MAb-BT-563 | Phase 3 Clinical | Eusa Pharma, Jazz Pharmaceuticals | Graft vs Host Disease | Details |
| Anti-interleukin-2 receptor monoclonal antibody Mikbeta1 | HuMikβ1-1 | Phase 1 Clinical | F. Hoffmann-La Roche Ltd, National Institutes Of Health | Leukemia, Lymphoid | Details |
| Basiliximab biobetter (Mabtech/Sorrento) | STI-003 | Phase 3 Clinical | Taizhou Maibo Taike Biotechnology Co Ltd | Autoimmune Diseases | Details |
| Camidanlumab tesirine | ADCT-301 | Phase 2 Clinical | Genmab, Adc Therapeutics | Lymphoma, Mantle-Cell; Carcinoma, Non-Small-Cell Lung; Melanoma; Leukemia, Lymphocytic, Chronic, B-Cell; Fallopian Tube Neoplasms; Waldenstrom Macroglobulinemia; Lymphoma, T-Cell, Cutaneous; Lymphoma, Non-Hodgkin; Lymphoma; Leukemia, Myeloid, Acute; Burkitt Lymphoma; Colorectal Neoplasms; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Lymphoma, T-Cell, Peripheral; Lymphoma, Follicular; Urinary Bladder Neoplasms; Pancreatic Neoplasms; Triple Negative Breast Neoplasms; Hodgkin Disease; Lymphoma, Large B-Cell, Diffuse; Squamous Cell Carcinoma of Head and Neck; Stomach Neoplasms; Esophageal Neoplasms; Carcinoma, Renal Cell; Ovarian Neoplasms; Solid tumours | Details |
| Inolimomab | B-B10; BT-563; MAb-BT-563 | Phase 3 Clinical | Eusa Pharma, Jazz Pharmaceuticals | Graft vs Host Disease | Details |
| Anti-interleukin-2 receptor monoclonal antibody Mikbeta1 | HuMikβ1-1 | Phase 1 Clinical | F. Hoffmann-La Roche Ltd, National Institutes Of Health | Leukemia, Lymphoid | Details |
| Basiliximab biobetter (Mabtech/Sorrento) | STI-003 | Phase 3 Clinical | Taizhou Maibo Taike Biotechnology Co Ltd | Autoimmune Diseases | Details |
| Camidanlumab tesirine | ADCT-301 | Phase 2 Clinical | Genmab, Adc Therapeutics | Lymphoma, Mantle-Cell; Carcinoma, Non-Small-Cell Lung; Melanoma; Leukemia, Lymphocytic, Chronic, B-Cell; Fallopian Tube Neoplasms; Waldenstrom Macroglobulinemia; Lymphoma, T-Cell, Cutaneous; Lymphoma, Non-Hodgkin; Lymphoma; Leukemia, Myeloid, Acute; Burkitt Lymphoma; Colorectal Neoplasms; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Lymphoma, T-Cell, Peripheral; Lymphoma, Follicular; Urinary Bladder Neoplasms; Pancreatic Neoplasms; Triple Negative Breast Neoplasms; Hodgkin Disease; Lymphoma, Large B-Cell, Diffuse; Squamous Cell Carcinoma of Head and Neck; Stomach Neoplasms; Esophageal Neoplasms; Carcinoma, Renal Cell; Ovarian Neoplasms; Solid tumours | Details |
This web search service is supported by Google Inc.
A-Z